共 50 条
Progress in central retinal artery occlusion: a narrative review
被引:11
|作者:
Liu, Weishai
[1
]
Bai, Dan
[1
]
Kou, Lieling
[1
,2
]
机构:
[1] Ankang Hosp Tradit Chinese Med, Dept Ophthalmol, Ankang, Peoples R China
[2] Ankang Hosp Tradit Chinese Med, 47 Bashan East Rd, Ankang City 725000, Ankang, Peoples R China
关键词:
Central retinal artery occlusion;
epidemiology;
pars plana vitrectomy;
treatment;
intra-arterial thrombosis;
intravenous thrombosis;
LOCAL INTRAARTERIAL FIBRINOLYSIS;
INTRAVENOUS THROMBOLYSIS;
PLASMINOGEN-ACTIVATOR;
COMPLICATIONS;
MANAGEMENT;
PATIENT;
STROKE;
EMBOLI;
RISK;
D O I:
10.1177/03000605231198388
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
Central retinal artery occlusion (CRAO) is a catastrophic ophthalmic emergency that severely impairs a patient's visual function, often reducing visual acuity to counting fingers or worse. Progress in CRAO research has provided new information regarding its epidemiological characteristics and led to useful assessments through various ophthalmic examinations. Additional insights about CRAO have been gained through studies of its pathophysiological mechanisms, improving intervention timing and enhancing patient prognosis. Treatment for CRAO has evolved, particularly with assistance from surgical instruments and surgical robots. Although surgical treatment is now possible, this option is not widely recognized by ophthalmologists. Conservative therapies have limited benefits compared with the natural course of disease. Recently, pars plana vitrectomy plus endovascular surgery has received considerable interest among ophthalmologists because of its potential efficacy in the treatment of CRAO. Considering the inconsistencies in rationale and efficacy of CRAO treatment modalities, it is important to distinguish between treatment effects and the natural courses of various CRAO subclasses. This narrative review explores progress in CRAO epidemiology, pathophysiology, ophthalmic examination, and treatment.
引用
收藏
页数:12
相关论文